Author:
Son Taewoong,Kim Minseo,Choi Minsuk,Nam Sang Hwan,Yoo Ara,Lee Hyunseung,Han Eun Hee,Hong Kwan Soo,Park Hye Sun
Abstract
Abstract
Background
Silica nanoparticles (SNPs) have immense potential in biomedical research, particularly in drug delivery and imaging applications, owing to their stability and minimal interactions with biological entities such as tissues or cells.
Results
With synthesized and characterized cyanine-dye-doped fluorescent SNPs (CSNPs) using cyanine 3.5, 5.5, and 7 (Cy3.5, Cy5.5, and Cy7). Through systematic analysis, we discerned variations in the surface charge and fluorescence properties of the nanoparticles contingent on the encapsulated dye-(3-aminopropyl)triethoxysilane conjugate, while their size and shape remained constant. The fluorescence emission spectra exhibited a redshift correlated with increasing dye concentration, which was attributed to cascade energy transfer and self-quenching effects. Additionally, the fluorescence signal intensity showed a linear relationship with the particle concentration, particularly at lower dye equivalents, indicating a robust performance suitable for imaging applications. In vitro assessments revealed negligible cytotoxicity and efficient cellular uptake of the nanoparticles, enabling long-term tracking and imaging. Validation through in vivo imaging in mice underscored the versatility and efficacy of CSNPs, showing single-switching imaging capabilities and linear signal enhancement within subcutaneous tissue environment.
Conclusions
This study provides valuable insights for designing fluorescence imaging and optimizing nanoparticle-based applications in biomedical research, with potential implications for targeted drug delivery and in vivo imaging of tissue structures and organs.
Graphical Abstract
Funder
KBSI
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Xiao D, Qi H, Teng Y, Pierre D, Kutoka PT, Liu D. Advances and challenges of fluorescent nanomaterials for synthesis and biomedical applications. Nanoscale Res Lett. 2021;16(167):1–23.
2. Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update post COVID-19 vaccines. Bioeng Transl Med. 2021;6: e10246.
3. Ma D, Kell AJ, Tan S, Jakubek ZJ, Simard B. Photophysical properties of dye-doped silica nanoparticles bearing different types of dye-silica interactions. J Phys Chem C. 2009;113:15974–81.
4. Janjua TI, Cao Y, Yu C, Popat A. Clinical translation of silica nanoparticles. Nat Rev Mater. 2021;6(12):1072–4.
5. Kharlamov AN, Tyurnina AE, Veselova VS, Kovtun OP, Shur VY, Gabinsky JL. Silica–gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. Nanoscale. 2015;7:8003–15.